• Renal Cell Carcinoma: A Critical Appraisal and a Look Forward

  By Cora N. Sternberg, MD, FACP

• Bone Metastases Module

  By Edward Chow MBBS, PhD, FRCPC

Case Studies

• A 64 year old retired pharmacist presents to his primary care physician with complaints of urinary urgency and frequency of 6 months duration and of increasingly severe low back and right hip pain of 3 months duration.

• A 73 year old retired commericial fisherman was diagnosed 3 years ago with a Stage IV [Gleason 3 + 3(6)] prostate cancer with bone being the only site of metastases.

• A 55 year old woman presents to her primary care physician with occasional gross painless hematuria for 4 months.

• A 59 year old male had a diagnosis of renal cell carcinoma of the left kidney made 2 years ago after presenting with flank pain and hematuria.

The Role of mTor in Cancer Cells - a presentation series

• Introductory Remarks

  By Prof. Stan B. Kaye, MD

• History Of Patupilone: From Bench to Clinic

  By Paul M.J. McSheehy, PhD

• Patupilone Ovarian Programme

  By Amit M. Oza, MD

• Patupilone Future Development Programme

  By Anandhi Johri, MD

• mTor: A New Pathway to Target in Oncology

  By Madlaina Breuleux, PhD

• New Strategies in the Management of Advanced Neuroendocrine Tumors

  By James C. Yao, MD

• Targeting Angiogenesis in Advanced Renal Cell Carcinoma: Clinical Results and Future Perspectives

  by Robert J. Amato, DO

• Conclusions

  By Prof. Stan B. Kaye, MD










American Urological Association (AUA) 2009 Annual Meeting

- View Renal Cancer Session Highlights
2010 Genitourinary Cancers Symposium

- View Renal Cancer Session Highlights
10th Annual Winter Meeting of the Society of Urologic Oncology (SUO)

- View Renal Cancer Session Highlights
Analysis of local relapse after laparoscopic and percutaneous cryoablation for renal tumors

- Highlight of a presentation by M. Tsivian, MD, et al. at the World Congress of Endourology (WCE)
Durable oncologic outcomes following radiofrequency ablation (RFA): Experience from treating 243 small renal masses over 7.5 years

- Highlight of a presentation by C. Tracy, MD, et al. at the World Congress of Endourology (WCE)
Are urology residents adequately exposed to treatment modalities for small renal masses?

- Highlight of a presentation by Vanessa L. Elliott, MD, et al. at the American Urological Association Mid-Atlantic Section - 67th Annual Meeting
Deutsche Gesellschaft für Urologie (DGU) German Society of Urology 61th Annual Congress

- View Renal Cancer Session Highlights
Laparoscopic or robotic renal surgery

- Slide presentation by Louis R. Kavoussi, MD at the 107th Annual Meeting of the AUA - New York Section
How to prevent complications during percutaneous renal surgery

- Slide presentation by Arthur D. Smith, MD at the 107th Annual Meeting of the AUA - New York Section
VI Maratona Urológica do Rio de Janeiro

- View Renal Cancer Slide Presentations
VI Maratona Urológica do Rio de Janeiro

- View Renal Cancer Session Highlights
American Society of Clinical Oncology 45th ASCO Annual Meeting

- View Renal Cancer Session Highlights
The American Urological Association 2009 Annual Meeting

- View Renal Cancer Session Highlights
High Risk Upper Tract TCC

- View a lecture presented by James McKiernan, MD at the 33rd Winter Urologic Forum
Ablation of Small Renal Masses: Cryo, RFA and HIFU

- View a slide presentation by Ihor Sawczuk, MD at the AUA NY Section 2008
Renal Cell Carcinoma

- View a slide presentation by Daniel P. Petrylak, MD at the Masters in Urology 2008
The American Urological Association (AUA) 2008 Annual Meeting

- View Renal Cancer Session Highlights
American Society of Clinical Oncology 44th ASCO Annual Meeting

- View Renal Cancer Session Highlights
Engineering and Urology Society (EUS) 23rd Annual Meeting 2008

- View Renal Cancer Abstracts
European Association of Urology (EAU) 23^rd Annual Congress

- View Renal Cancer Session Highlights